Jiang, H.; Wang, B.; Zhang, F.; Qian, Y.; Chuang, C.-C.; Ying, M.; Wang, Y.; Zuo, L.
The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer. Int. J. Mol. Sci. 2016, 17, 1803.
https://doi.org/10.3390/ijms17111803
AMA Style
Jiang H, Wang B, Zhang F, Qian Y, Chuang C-C, Ying M, Wang Y, Zuo L.
The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer. International Journal of Molecular Sciences. 2016; 17(11):1803.
https://doi.org/10.3390/ijms17111803
Chicago/Turabian Style
Jiang, Huayong, Bin Wang, Fuli Zhang, Yuanyu Qian, Chia-Chen Chuang, Mingzhen Ying, Yajie Wang, and Li Zuo.
2016. "The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer" International Journal of Molecular Sciences 17, no. 11: 1803.
https://doi.org/10.3390/ijms17111803
APA Style
Jiang, H., Wang, B., Zhang, F., Qian, Y., Chuang, C. -C., Ying, M., Wang, Y., & Zuo, L.
(2016). The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer. International Journal of Molecular Sciences, 17(11), 1803.
https://doi.org/10.3390/ijms17111803